Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H20N2O.ClH |
| Molecular Weight | 268.782 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCC(=O)N(C1CCNCC1)C2=CC=CC=C2
InChI
InChIKey=KQGAIRYUMBGZQC-UHFFFAOYSA-N
InChI=1S/C14H20N2O.ClH/c1-2-14(17)16(12-6-4-3-5-7-12)13-8-10-15-11-9-13;/h3-7,13,15H,2,8-11H2,1H3;1H
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors. | 2007-11-01 |
|
| Development of an enzyme-linked immunosorbent assay for fentanyl and applications of fentanyl antibody-coated nanoparticles for sample preparation. | 2006-06-16 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
68720038
Created by
admin on Wed Apr 02 13:58:01 GMT 2025 , Edited by admin on Wed Apr 02 13:58:01 GMT 2025
|
PRIMARY | |||
|
22352-81-4
Created by
admin on Wed Apr 02 13:58:01 GMT 2025 , Edited by admin on Wed Apr 02 13:58:01 GMT 2025
|
PRIMARY | |||
|
DTXSID10858216
Created by
admin on Wed Apr 02 13:58:01 GMT 2025 , Edited by admin on Wed Apr 02 13:58:01 GMT 2025
|
PRIMARY | |||
|
QZN69FF3RF
Created by
admin on Wed Apr 02 13:58:01 GMT 2025 , Edited by admin on Wed Apr 02 13:58:01 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
